Mediators of immediate hypersensitivity.

[1]  D. Fearon,et al.  Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. , 1983, Journal of immunology.

[2]  B. Seligmann,et al.  Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. , 1983, Journal of immunology.

[3]  E. Corey,et al.  Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells. , 1983, Journal of immunology.

[4]  G. Lazarus,et al.  Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I. , 1983, The Journal of biological chemistry.

[5]  A. Wissner,et al.  Hypotensive and vasodilatory activity of (+/-) 1-o-octadecyl-2-acetyl glyceryl-3-phosphorylcholine in the normotensive rat. , 1983, Life sciences.

[6]  E. R. Mcfadden,et al.  Exercise-induced anaphylaxis: a distinct form of physical allergy. , 1983, The Journal of allergy and clinical immunology.

[7]  E. R. Mcfadden,et al.  Effects of leukotriene D on the airways in asthma. , 1983, The New England journal of medicine.

[8]  L. Touqui,et al.  Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite. , 1983, Biochemical and biophysical research communications.

[9]  M. Kaliner,et al.  Measurement of urinary histamine: comparison of fluorometric and radioisotopic-enzymatic assay procedures. , 1983, The Journal of allergy and clinical immunology.

[10]  K. Frank Austen,et al.  Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin , 1983 .

[11]  J. Benveniste,et al.  Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. , 1983, European journal of pharmacology.

[12]  W. Henderson,et al.  Leukotriene B4, C4, D4 and E4 inactivation by hydroxyl radicals. , 1983, Biochemical and biophysical research communications.

[13]  G. Dusting,et al.  Coronary vasoconstriction induced by leukotrienes in the anaesthetized dog. , 1982, European journal of pharmacology.

[14]  C. Page,et al.  Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma? , 1982, European journal of pharmacology.

[15]  J. Trzeciakowski,et al.  Reduction of ventricular fibrillation threshold by histamine: resolution into separate H1- and H2-mediated components. , 1982, The Journal of pharmacology and experimental therapeutics.

[16]  B. Zweiman,et al.  Antigen-induced neutrophil chemotactic activity from sensitized lung. , 1982, The Journal of allergy and clinical immunology.

[17]  W. Campbell,et al.  Stimulation of prostaglandin formation by vasoactive mediators in cultured human endothelial cells. , 1982, Prostaglandins.

[18]  J. Oates,et al.  Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. , 1982, Journal of immunology.

[19]  S. Peters,et al.  Generation of leukotrienes by purified human lung mast cells. , 1982, The Journal of clinical investigation.

[20]  S. Wasserman,et al.  Mast cells in allergic diseases and mastocytosis. , 1982, The Western journal of medicine.

[21]  R. Schellenberg,et al.  The effects of salbutamol, theophylline and FPL55712 on leukotriene contraction of guinea pig trachea. , 1982, European journal of pharmacology.

[22]  B. Vargaftig,et al.  Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of "platelet-activating factor" (PAF-acether). , 1982, European journal of pharmacology.

[23]  D. Metcalfe,et al.  Measurement of plasma histamine: description of an improved method and normal values. , 1982, The Journal of allergy and clinical immunology.

[24]  K. Austen,et al.  Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-disulfate. , 1982, The Journal of biological chemistry.

[25]  M. Katori,et al.  Possible involvement of thromboxane in bronchoconstrictive and hypertensive effects of LTC4 and LTD4 in guinea pigs. , 1982, Prostaglandins.

[26]  H. Dvorak,et al.  Ultrastructural identification of the mouse basophil. , 1982, Blood.

[27]  J. O'flaherty,et al.  Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. , 1982, The Journal of biological chemistry.

[28]  R. Murphy,et al.  Leukotriene C4 and D4 formation by particulate enzymes. , 1982, The Journal of biological chemistry.

[29]  C. Piantadosi,et al.  Platelet activating factor (1‐O‐alkyl‐2‐O‐acetyl‐sn‐glycero‐3‐phosphocholine) , 1982, FEBS letters.

[30]  L. Boxer,et al.  Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). , 1982, Journal of immunology.

[31]  E. Daniel,et al.  Pharmacological study of the contractile activity of leukotriene C4 and D4 on isolated human airway smooth muscle. , 1982, Canadian journal of physiology and pharmacology.

[32]  F. Snyder,et al.  Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. , 1982, Biochemical and biophysical research communications.

[33]  M. Walport,et al.  Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. , 1982, The Journal of clinical investigation.

[34]  L. McManus,et al.  Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[35]  E. Corey,et al.  Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. , 1982, The Journal of pharmacology and experimental therapeutics.

[36]  A. B. Kay,et al.  Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. , 1982, The New England journal of medicine.

[37]  K. Austen,et al.  The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria. , 1982, Clinical and experimental immunology.

[38]  D. Webb,et al.  Immunosuppressive properties of leukotriene D4 and E4 in vitro. , 1982, Biochemical and biophysical research communications.

[39]  N. Soter,et al.  Abnormal histamine-induced suppressor-cell function in atopic subjects. , 1982, The New England journal of medicine.

[40]  W. Henderson,et al.  Leukotriene generation by eosinophils , 1982, The Journal of experimental medicine.

[41]  L. Appelgren,et al.  Distribution and metabolism of 3H-labeled leukotriene C3 in the mouse. , 1982, The Journal of biological chemistry.

[42]  M. Kaliner,et al.  Prostaglandin-generating factor of anaphylaxis. Identification and isolation. , 1981, The Journal of biological chemistry.

[43]  J. Coleman,et al.  The number and affinity of IgE receptors on dispersed human lung mast cells. , 1981, Immunology.

[44]  K.,et al.  Tryptase from human pulmonary mast cells. Purification and characterization. , 1981, The Journal of biological chemistry.

[45]  D. Hanahan,et al.  Influence of alkyl ether chain length of acetyl glyceryl ether phosphorylcholine and its ethanolamine analog on biological activity toward rabbit platelets. , 1981, Archives of biochemistry and biophysics.

[46]  M. Kaliner,et al.  The biologic activity of mast cell granules. III. Purification of inflammatory factors of anaphylaxis (IF-A) responsible for causing latephase reactions. , 1981, Journal of immunology.

[47]  L. McManus,et al.  Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[48]  J. O'flaherty,et al.  Anaphylactic actions of platelet-activating factor. , 1981, The American journal of pathology.

[49]  B. Zweiman,et al.  Mediator release in local heat urticaria. , 1981, The Journal of allergy and clinical immunology.

[50]  K. Bernström,et al.  Metabolism of leukotriene D by porcine kidney. , 1981, The Journal of biological chemistry.

[51]  L. McManus,et al.  Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor). , 1981, Journal of immunology.

[52]  S. Dahlén,et al.  Rapid invivo metabolism of Leukotriene C3 in the monkey, Macacairus , 1981 .

[53]  F. Snyder,et al.  In vivo metabolism of a new class of biologically active phospholipids: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a platelet activating-hypotensive phospholipid. , 1981, Life sciences.

[54]  S. Strobel,et al.  Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. , 1981, Journal of clinical pathology.

[55]  Y. C. Kang,et al.  Enzymatic inactivation of SRS-Cys-Gly (leukotriene D). , 1981, Biochemical and biophysical research communications.

[56]  R. Lavker,et al.  Histamine suppression of in vivo eosinophil accumulation and histamine release in human allergic reactions. , 1981, The Journal of allergy and clinical immunology.

[57]  G. Rossoni,et al.  Leukotriene-C4 induces generation of PGI2 and TXA2 in guinea-pig in vivo. , 1981, Pharmacological research communications.

[58]  C. Piantadosi,et al.  Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. , 1981, Biochemical and biophysical research communications.

[59]  K. A. Knauer,et al.  Platelet activation during antigen-induced airway reactions in asthmatic subjects. , 1981, The New England journal of medicine.

[60]  K. Austen,et al.  Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells. , 1981, Journal of immunology.

[61]  L. McManus,et al.  Modification of the polar head group of acetyl glyceryl ether phosphorylcholine and subsequent effects upon platelet activation. , 1981, The Journal of biological chemistry.

[62]  D. Seldin,et al.  Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. , 1981, Journal of immunology.

[63]  L. McManus,et al.  Human platelet stimulation by acetyl glyceryl ether phosphorylcholine. , 1981, The Journal of clinical investigation.

[64]  G. Camussi,et al.  Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. , 1981, Immunology.

[65]  F. Snyder,et al.  A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). , 1981, The Journal of biological chemistry.

[66]  J. Oates,et al.  Increased production of prostaglandin D2 in patients with systemic mastocytosis. , 1980, The New England journal of medicine.

[67]  J. Shelhamer,et al.  Immunologic and neuropharmacologic stimulation of mucous glycoprotein release from human airways in vitro. , 1980, The Journal of clinical investigation.

[68]  F. Snyder,et al.  Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid. , 1980, The Journal of biological chemistry.

[69]  R. Lavker,et al.  Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions. , 1980, The Journal of allergy and clinical immunology.

[70]  P. L. Smith,et al.  Physiologic manifestations of human anaphylaxis. , 1980, The Journal of clinical investigation.

[71]  T. Ahmed,et al.  Role of H1- and H2-receptors in airway reactions to histamine in conscious sheep. , 1980, Journal of applied physiology: respiratory, environmental and exercise physiology.

[72]  C. Dollery,et al.  Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. , 1980, The New England journal of medicine.

[73]  F. Sun,et al.  Calcium stimulation of a novel lipoxygenase. , 1980, Biochemical and biophysical research communications.

[74]  R. Murphy,et al.  Leukotrienes and Slow Reacting Substance of Anaphylaxis (SRS‐A) , 1980, Allergy.

[75]  J. Liehr,et al.  Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. , 1980, The Journal of biological chemistry.

[76]  L. McManus,et al.  Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit. , 1980, Journal of immunology.

[77]  K. Austen,et al.  Secretion in dissociated human pulmonary mast cells. Evidence for solubilization of granule contents before discharge , 1980, The Journal of cell biology.

[78]  M. Steinhoff,et al.  Enzymatic formation of prostaglandin D2 by rat basophilic leukemia cells and normal rat mast cells. , 1980, Biochimica et biophysica acta.

[79]  K. Austen,et al.  Identification of sulfated mucopolysaccharides including heparin in the lesional skin of a patient with mastocytosis. , 1980, The Journal of investigative dermatology.

[80]  E. R. Mcfadden,et al.  Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. , 1980, The New England journal of medicine.

[81]  R. Farr,et al.  Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). , 1980, Clinical immunology and immunopathology.

[82]  P. Henson,et al.  Human neutrophil-derived platelet activating factor. , 1980, Journal of immunology.

[83]  K. Austen,et al.  Isolation and characterization of heparin from human lung. , 1979, The Journal of clinical investigation.

[84]  J. Oates,et al.  Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. , 1979, Biochimica et biophysica acta.

[85]  F. Snyder,et al.  Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. , 1979, Biochemical and biophysical research communications.

[86]  K. Austen,et al.  Immunologic Release of β-Hexosaminidase and β-Glucuronidase from Purified Rat Serosal Mast Cells , 1979, The Journal of Immunology.

[87]  Y. Kitamura,et al.  Distribution of mast-cell precursors in hematopoeitic and lymphopoietic tissues of mice , 1979, The Journal of experimental medicine.

[88]  K. Austen,et al.  Oral disodium cromoglycate in the treatment of systemic mastocytosis. , 1979, The New England journal of medicine.

[89]  L. Lichtenstein,et al.  Anaphylactic release of a basophil kallikrein-like activity. I. Purification and characterization. , 1979, The Journal of clinical investigation.

[90]  R. Murphy,et al.  Introduction of a nomenclature: leukotrienes. , 1979, Prostaglandins.

[91]  Y. Kitamura,et al.  Presence of mast cell precursors in peripheral blood of mice demonstrated by parabiosis. , 1979, Blood.

[92]  W. Henderson,et al.  Mast cell granule peroxidase: location, secretion, and SRS-A inactivation. , 1979, Journal of immunology.

[93]  M. Kaliner,et al.  The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation. , 1978, The Journal of clinical investigation.

[94]  H. Neurath,et al.  Purification of an atypical mast cell protease and its levels in developing rats. , 1978, Biochemistry.

[95]  B. Zweiman,et al.  Antigen-induced neutrophil chemotactic activity in man. Correlation with bronchospasm and inhibition by disodium cromoglycate. , 1978, The Journal of allergy and clinical immunology.

[96]  L. Lichtenstein,et al.  IgE receptors on human basophils. Relationship to serum IgE concentration. , 1978, The Journal of clinical investigation.

[97]  J. Weiler,et al.  Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin , 1978, The Journal of experimental medicine.

[98]  E. Goetzl,et al.  Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT). , 1978, Journal of immunology.

[99]  E. Goetzl,et al.  Immunologic release in the rat peritoneal cavity lipid chemotactic and chemokinetic factors for polymorphonuclear leukocytes. , 1978, Journal of immunology.

[100]  K. Austen,et al.  Preparative purification of the rat mast cell chymase. Characterization and Interaction with granule components , 1977, The Journal of experimental medicine.

[101]  K. Austen,et al.  Identification and characterization of arylsulfatase A and B of the rat basophil leukemia tumor. , 1977, Journal of Biological Chemistry.

[102]  A. Kay,et al.  The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors , 1977, Nature.

[103]  C. F. Schott,et al.  Isolation of the cytoplasmic granules of guinea pig basophilic leukocytes: identification of esterase and protease activities. , 1977, Journal of immunology.

[104]  K.,et al.  Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. , 1977, The Journal of clinical investigation.

[105]  B. Zweiman,et al.  Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans. , 1977, Annals of internal medicine.

[106]  M. Wasserman,et al.  Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog. , 1977, Prostaglandins.

[107]  K. Austen,et al.  Native heparin from rat peritoneal mast cells. , 1977, The Journal of biological chemistry.

[108]  M. Hamberg,et al.  Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. , 1976, The Journal of biological chemistry.

[109]  K. Austen,et al.  Release of chemical mediators from partially purified human lung mast cells. , 1976, Journal of immunology.

[110]  G. Solley,et al.  The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. , 1976, The Journal of clinical investigation.

[111]  E. Goetzl,et al.  Isolation of human eosinophil phospholipase D. , 1976, The Journal of clinical investigation.

[112]  K. Austen,et al.  Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. , 1976, The New England journal of medicine.

[113]  H. Okudaira,et al.  Development of rat mast cells in vitro. I. Differentiation of mast cells from thymus cells. , 1976, Journal of immunology.

[114]  Fräki Je,et al.  Human skin proteases: separation and characterization of two alkaline proteases, one splitting trypsin and the other chymotrypsin substrates. , 1975 .

[115]  A. Kay,et al.  Passive sensitization of guinea-pig skin in vitro for the antigen-induced release of anaphylactic mediators. , 1974, Clinical and Experimental Immunology.

[116]  E. Goetzl,et al.  Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). , 1974, Journal of immunology.

[117]  K. Austen,et al.  Detection of slow reacting substance of anaphylaxis (SRS-A) in plasma of guinea pigs during anaphylaxis. , 1973, Journal of immunology.

[118]  J B Farmer,et al.  Selective inhibitor of slow reacting substance of anaphylaxis. , 1973, Nature: New biology.

[119]  L. Lichtenstein,et al.  Inhibition of Histamine Release by Histamine controlled by H2 Receptor , 1973, Nature.

[120]  L. Lichtenstein,et al.  Studies on the mechanism of lymphocyte-mediated cytolysis. IV. Specificity of the histamine receptor on effector T cells. , 1973, Journal of immunology.

[121]  F. Hargreave,et al.  Late cutaneous allergic responses in isolated IgE-dependent reactions. , 1973, The Journal of allergy and clinical immunology.

[122]  K. de Vries,et al.  Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. , 1971, The Journal of allergy and clinical immunology.

[123]  K. Austen,et al.  The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. , 1971, Journal of immunology.

[124]  W. Crosby,et al.  Cytochemical identification of monocytes and granulocytes. , 1971, American journal of clinical pathology.

[125]  K. F. Austen,et al.  AN EOSINOPHIL LEUKOCYTE CHEMOTACTIC FACTOR OF ANAPHYLAXIS , 1971, The Journal of experimental medicine.

[126]  D. Lagunoff,et al.  DIFFERENTIATION AND PROLIFERATION OF EMBRYONIC MAST CELLS OF THE RAT , 1965, The Journal of cell biology.

[127]  G. Palade,et al.  STUDIES ON INFLAMMATION , 1961, The Journal of biophysical and biochemical cytology.

[128]  B. Rose.  Studies on blood histamine in cases of allergy: I. Blood histamine during wheal formation , 1941 .

[129]  E. Corey,et al.  Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes. , 1983, Immunology.

[130]  E. Goetzl,et al.  Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. , 1983, Immunology.

[131]  B. Zweiman,et al.  Plasma concentrations of histamine measured by radioenzymatic assay: effects of histaminase incubations. , 1982, The Journal of allergy and clinical immunology.

[132]  P. Ind,et al.  A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics. , 1982, The Journal of allergy and clinical immunology.

[133]  D. Hanahan,et al.  Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[134]  J. Mencia-Huerta,et al.  Release of platelet‐activating factor (PAF‐acether) and leukotrienes C and D from inflammatory macrophages , 1982, European journal of immunology.

[135]  H. Metzger,et al.  Stimulus-secretion coupling in rat basophilic leukemia cells. , 1981, Kroc Foundation series.

[136]  F. Hirata,et al.  Transmission and regulation of triggering signals induced by bridging of IgE receptors on rat mast cells. , 1981, Kroc Foundation series.

[137]  H. Dvorak,et al.  Basophils and Mast Cells: Structure, Function, and Role in Hypersensitivity , 1979 .

[138]  K. Austen,et al.  Inhibition of neutrophil chemotaxis in association with experimental angioedema in patients with cold urticaria: a model of chemotactic deactivation in vivo. , 1979, Clinical and Experimental Immunology.

[139]  W. Henderson,et al.  Immunologic and nonimmunologic generation of superoxide from mast cells and basophils. , 1978, The Journal of clinical investigation.

[140]  Austen Kf,et al.  Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: immunologic release, granule association, and demostration of structura heterogeneity. , 1978 .

[141]  A. Kay,et al.  Human eosinophils, acidic tetrapeptides (ECF-A) and histamine. Interactions in vitro and in vivo. , 1977, Immunology.

[142]  E. Goetzl,et al.  Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. , 1977, The Journal of clinical investigation.